GAD-7 questionnaire for anxiety symptoms

Diabetes Academy: Resources and Solutions

Verified sources Updated: October 29, 2026

You can answer the seven questions about the last two weeks, and the calculator adds up the points and shows which severity range your anxiety score falls into.

1. Feeling nervous, anxious or on edge
2. Not being able to stop or control worrying
3. Worrying too much about different things
4. Trouble relaxing
5. Being so restless that it is hard to sit still
6. Becoming easily annoyed or irritable
7. Feeling afraid, as if something awful might happen

The questions refer to the last two weeks. The questionnaire is a screening tool, not a diagnosis, and you should discuss the result with your doctor.

The calculation runs in your browser; no data is sent or stored. The result is for information only and does not replace assessment by your doctor.

What does the GAD-7 questionnaire measure?

GAD-7 (Generalized Anxiety Disorder) measures how often seven anxiety symptoms have bothered you over the last two weeks. Each question is scored from 0 to 3, so the total runs from 0 to 21 [1].

The scale was developed in patients seen in primary care. Anxiety and depression remain separate dimensions, even though they often occur together. Like the PHQ-9 (for depression), the GAD-7 form is free for anyone to use.

What does my GAD-7 score mean?

The published cutoffs are 5, 10 and 15 points, separating minimal symptoms from mild, moderate and severe anxiety [1]. The usual threshold for referral is 10.

For cutoffs between 7 and 10 points, sensitivity and specificity are acceptable [2]. A score of 10 or above is therefore a good reason to raise the subject with a doctor.

Anxiety is more common in patients with diabetes, and some of the symptoms overlap with those of the disease itself [3]. That is why anxiety symptoms are screened for in all patients with diabetes at least once a year [4]. Restlessness, tremor, sweating and a pounding heart are also signs of hypoglycemia, which sometimes makes it hard to tell what is going on. If you have these signs and you are treated with insulin or with tablets that can cause hypoglycemia, check your blood glucose before putting them down to anxiety [5].

There is also a distinct form, fear of hypoglycemia, which appears for instance after a severe hypoglycemic episode and can lead to deliberately keeping blood glucose too high [4]. If you recognize the pattern, read about hypoglycemia and how to prevent it, then bring it up at your next appointment.

Do GAD-7 and PHQ-9 measure the same thing?

No. The two scales measure distinct dimensions, with independent effects on daily functioning [1]. Anxiety revolves around worry and restlessness, depression around loss of interest and discouragement.

They often overlap, and many people score high on both. That is why the two questionnaires are usually completed together, and if you have not done the other one yet you can find it on the PHQ-9 questionnaire page.

References

  1. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097. PubMed
  2. Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24-31. PubMed
  3. Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2026 Sep 16. Online ahead of print. PubMed
  4. American Diabetes Association Professional Practice Committee. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S89-S131. PubMed
  5. American Diabetes Association Professional Practice Committee. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S132-S149. PubMed
Glossary terms used here